Skip to content

Compare the effect of two medicines sudha parpati and shankha bhasma on pimples

Pharmaceutical and comparitive clinical study of sudha parpati and shankha bhasma on mukha dooshika - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058523
Enrollment
40
Registered
2023-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: 3- Administration Health Condition 3: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 4: L988- Other specified disorders of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr.Shamja C Shamsudheen
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients irrespective of gender 2.Patients including teenagers with the age limit up to 30 yrs.

Exclusion criteria

Exclusion criteria: 1.Patients having infected pidaka with ulcer, kushta 2.Pidaka erupting in places except mukha 3.Under any systemic disease or any concomitant medication like NSAIDs 4.Undertaking oral antibiotics within last one month

Design outcomes

Primary

MeasureTime frame
Reduction of Pimples in patientsTimepoint: on day 22

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDrShamja C Shamsudheen

Sri Jayendra Saraswathi Ayurveda College and Hospital

virupakshgupta@gmail.com8555805497

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026